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PURPOSE. We previously reported that applying toll-like receptor (TLR) ligands to an injured
cornea induces corneal edema at 24 hours, which subsides by 1 week. We tested the
hypotheses that endothelial expression of the tight-junction protein, zonula occludens-1 (ZO-
1), would be altered during experimental sterile corneal inflammation and that endothelial
cell density (ECD) would remain unaffected.
METHODS. Anesthetized C57BL/6J mice received central 1-mm corneal abrasions followed by
topical application of saline or cytosine-phosphate-guanosine oligodeoxynucleotide (CpG-
ODN, TLR-9 agonist). At 24 hours, 1 week and 4 weeks post treatment, spectral-domain
optical coherence tomography images were captured. Eyes were enucleated and processed
for zonula occludens-1 (ZO-1) immunofluorescent staining. Corneal flatmounts were
analyzed for endothelial ZO-1 expression, cell density, polymegethism, and polymorphism.
Corneal stromal inflammatory cell infiltration was evaluated at 4 weeks by immunostaining
for CD45.
RESULTS. Central corneal thickness (CCT) was increased in CpG-ODN treated eyes at 24 hours,
had normalized by 1 week, but was again thickened by 4 weeks. In eyes with CpG-ODN,
endothelial cell ZO-1 expression was reduced at 24 hours but returned to normal levels by 1
week. Endothelial cell density was not altered at 24 hours or 1 week. By 4 weeks, only CpG-
ODN eyes showed relatively reduced ECD, as well as large numbers of CD45þ cells in the
stroma. Changes to ECD correlated with CCT (r ¼ 0.53, P < 0.01). Compared with na¨ıve
controls, more saline- and CpG-ODN–treated eyes exhibited polymegethism.
CONCLUSIONS. This study provides novel insights into the interplay between endothelial cell
integrity, corneal edema, and chronic stromal leukocyte activation during sterile corneal
inflammation in mice.
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The integrity of the corneal endothelium is critical for themaintenance of stromal hydration and transparency. Injury
or inflammation to this nonregenerative cell monolayer can
have serious negative impacts upon corneal transparency and
vision. Excluding corneal dystrophies, a range of inflammatory-
mediated conditions, such as infectious keratitis,1 anterior
uveitis,2 corneal graft rejection,3 and dry eye disease4 can affect
the integrity of the corneal endothelium. Owing to the
availability of noninvasive clinical imaging modalities, including
slit lamp biomicroscopy and confocal laser scanning ophthal-
moscopy,5 the corneal endothelium can be readily visualized
and monitored during the course of disease or inflammatory
processes in humans and rodents. Furthermore, corneal
endothelial integrity can be assessed indirectly by monitoring
corneal edema in mice using spectral-domain optical coherence
tomography (SD-OCT).6
Breakdown in endothelial tight junctions is associated with
impaired ability of the cornea to control fluid uptake from the
anterior chamber, leading to corneal edema and compromised
light transmittance.7 Epithelial stress, including hypoxia, is
associated with aberrant expression of tight junctions between
endothelial cells.8 In studies of bovine endothelial cell cultures,
exposure to the proinflammatory cytokine TNF-a causes a
discontinuation of the apical endothelial tight junction protein
zonula occludens-1 (ZO-1) and loss of transendothelial electri-
cal resistance.9 In similar studies, TNF-a–induced impairment of
the endothelial tight junctions can be experimentally abrogated
by inhibition of matrix metalloproteinase-9 (MMP-9).10 In light
of the ability of proinflammatory cytokines to affect tight
junction expression in the corneal endothelium, we investigat-
ed the consequences of sterile, innate inflammation in the
mouse cornea following topical application of the toll-like
receptor (TLR)-9 agonist, cytosine-phosphate-guanosine (CpG)-
DNA.
Application of TLR-9 ligand CpG-oligodeoxynucleotide
(ODN) to the injured mouse cornea induces an acute phase
of neutrophil and macrophage infiltration and corneal ede-
ma6,11,12 followed by a later accumulation of giant macrophages
in the stroma and keratic precipitates on the corneal
endothelium.13 The accumulation of keratic precipitates is
not associated with overt structural changes to the corneal
endothelium, and corneal edema largely subsides by 1 week,
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suggesting that the presence of inflammatory cells in the
cornea is not associated with corneal endothelial dysfunction.
To explore the mechanisms of increased corneal edema during
the acute phase of CpG-induced corneal inflammation, we
investigated the expression of the tight junction protein ZO-1
by corneal endothelial cells and the density of corneal
endothelial cells. We also investigated the longer-term effects
of CpG-induced corneal inflammation to determine if CpG-
induced corneal inflammation was associated with any
detrimental effects to the corneal endothelium at later time
points.
We tested the hypothesis that endothelial expression of
the tight junction protein ZO-1 would be altered during
experimental sterile corneal inflammation. The relationship
between corneal edema, endothelial ZO-1 expression, and
endothelial cell density (ECD) was also examined to
determine if corneal edema was associated with a compro-
mised endothelium.
METHODS
Animals
A total of 70 female C57BL/6J mice, aged 7 to 8 weeks, were
obtained from the Animal Resources Centre (Canning Vale,
WA, Australia) and housed at the Florey Institute of Neurosci-
ence and Mental Health under specific pathogen-free condi-
tions. All animals were treated in accordance with the
guidelines of the Animal Ethics Committee at the University
of Melbourne, Australia, and the Florey Institute of Neurosci-
ence and Mental Health and all animal procedures conformed
to the ARVO Statement for the Use of Animals in Ophthalmic
and Vision Research.
Mouse Model of Corneal Inflammation
Mice were anesthetized with an intraperitoneal injection of
ketamine (80 mg/kg) and xylazine (10 mg/kg) and the
epithelium of the central cornea (1 mm diameter) was
debrided using an ophthalmic burr (Algerbrush II; Alger
Equipment Co., Lago Vista, TX, USA), as previously
described.6 Following the central corneal abrasion, 20 lg of
phosphorothioate CpG 1826 (type B, TLR-9 ligand; Inviv-
ogen, San Diego, CA, USA) or sterile saline was applied to
each eye. Animals were euthanized at 24 hours, 1 week and 4
weeks after treatment by lethal injection of sodium pento-
barbitone (Lethabarb; Virbac Pty Ltd., Milperra, NSW,
Australia).
Spectral-Domain OCT
Mice were anesthetized and a drop of sterile saline was
applied to the eye to prevent corneal drying. Mice were
placed on the animal imaging mount and rodent alignment
stage (AIM-RAS) attached to an SD-OCT imaging device
(Bioptigen Envisu R2200 VHR; Bioptigen, Inc., Durham, NC,
USA). Once the eye was aligned with the noncontact
objective lens, any excess saline was absorbed using a cotton
tip. Volumetric 4 3 4 mm rectangular scans of the anterior
segment (1000 A-scans/100 B-scans) were captured using an
OCT device with an 18-mm telecentric lens (Envisu R-2200;
Bioptigen, NC, USA) at baseline (Figs. 1A, 1B), 24 hours, 1
week, and 4 weeks post corneal injury and topical application
of CpG-ODN or saline. We analyzed OCT scans using ImageJ
software (http://imagej.nih.gov/ij/; provided in the public
domain by the National Institutes of Health, Bethesda, MD,
USA).
Quantification of Central Corneal Thickness (CCT)
From SD-OCT Scans
Total CCT was quantified, using the 43 4 mm SD-OCT images,
as the distance from epithelium to endothelium at a point
where a vertical line was orthogonal to the anterior-corneal
curvature. Epithelial and stromal thicknesses were also
quantified. A central image frame was determined, as we have
previously described,6 and CCT was taken as the mean
measure from 11 frames, being the central image frame, five
adjacent superior and inferior image frames.
Wholemount Immunofluorescence
Eyes were enucleated and fixed in 4% paraformaldehyde
overnight at 48C (Sigma-Aldrich Corp., Castle Hill, NSW,
Australia). Corneal wedges were dissected and incubated in
20 mM EDTA at 378C for 60 minutes, followed by blocking
buffer containing 3% bovine serum albumin (BSA) and 0.3%
Triton X-100. Corneas were incubated overnight in blocking
buffer containing rabbit anti-ZO-1 (anti-ZO-1, 1:500; Invitrogen,
Camarillo, CA, USA) primary antibody. In a subset of animals
from the 4-week time point, rat anti-mouse CD45 (1:400; BD
Pharmingen, San Diego, CA, USA) was included in the staining
protocol. Tissues were washed with PBS and incubated in
secondary goat anti-rabbit biotin (1:300; Vector Laboratories,
Burlingame, CA, USA) for 3 hours followed by Streptavidin Cy3
(1:400; Jackson ImmunoResearch, West Grove, PA, USA) or
goat anti-rat 488 (1:500; Invitrogen, Carlsbad, CA, USA)
secondary antibody for 45 minutes. In order to visualize cell
nuclei, all tissues were incubated with fluorescent dye
(Hoechst, 1:500; Roche Applied Science, Mannheim, Germany)
for 10 minutes at room temperature before cover slipping.
Stained corneas were mounted on glass slides with the corneal
epithelium facing downward.
Confocal Imaging and Quantification of ECD
To quantify the density of CD45þ cells in the stroma at 4 weeks
post treatment, full thickness confocal z-series were collected
from the central cornea of a subset of animals using a 340
objective lens; CD45þ cells were counted in ImageJ. To
quantify the expression of endothelial ZO-1 and ECD, two
randomly selected areas of the central corneal endothelium
(Fig. 1C) were imaged using a 340 objective lens (Confocal
Laser Scanning Platform SP8; Leica Microsystems, Buffalo
Grove, IL, USA), representing an area of 168,200 lm2. Corneal
endothelial cells were manually counted using FIJI/Image J and
converted to cells/mm2. The relative intensity of ZO-1
expression was determined by calculating the mean number
of intensity peaks exceeding a noise threshold, defined as 2-
fold above average pixel intensity, using the plot profile
function in ImageJ (Fig. 1D).
Image Processing and Cell Segmentation
Confocal images of ZO-1 immunostained corneas were
analyzed using FIJI software.14 Maximum intensity z-stacks
were generated and the red channel (ZO-1) was isolated to
show only the corneal endothelial cell membrane (Fig. 1E). To
correct for any uneven background illumination, a pseudo flat-
field correction was performed by subtracting a duplicate
Gaussian blurred background (‘‘Pseudo flat field correction’’)
from the image. Contrast was then enhanced (‘‘Enhance
contrast’’) followed by binary conversion, which was per-
formed using Li’s method of thresholding (‘‘Auto Thresh-
old’’).15 The image was further processed using a series of
binary operations (‘‘Binary. . .’’) to enhance the appearance of
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the endothelial borders and allow for the creation of a
skeletonized representation of the endothelial layer using a
Voronoi matrix (Fig. 1F).
ECD and Polymegethism
The central 50% of the resultant image (205 3 205 lm) was
defined as a region of interest (ROI) and analyzed using
‘‘Particle Analyzer. . .’’ to quantify endothelial cell number, cell
area, and also the area of each endothelial cell nucleus. The
degree of endothelial cell polymegethism, measured by
quantifying variability in corneal endothelial cell size and
nucleus size, was also analyzed. The mean cell area within the
ROI was divided by the standard deviation to determine the
coefficient of variation (CoV).16 At each time point, the mean
CoV of na¨ıve (untreated) eyes was used to define a threshold
value for ‘‘physiological polymegethism.’’ The proportion of
eyes with a CoV above this criterion in each group was
analyzed to quantify the amount of nonphysiological corneal
endothelial cell polymegethism.
Endothelial Cell Polymorphism
Images were processed as above using FIJI software with the
BioVoxxel Toolbox (http://imagej.net/BioVoxxel_Toolbox;
provided in the public domain by the National Institutes of
Health, Bethesda, MD, USA). Hexagonality was determined by
identifying cells with six adjacent neighbors using ‘‘BioVoxxel
Toolbox. . .,’’ ‘‘Neighbor Analysis’’ (Fig. 1G, green cells). This
returned a total count of all cells present and their
corresponding number of neighbors. To assess for endothelial
cell polymorphism, herein defined as the degree of departure
from a hexagonal cell shape, a hexagonality index was derived
by dividing the number of six-sided cells by the total number of
cells. A hexagonality index of 1 therefore represents all cells
FIGURE 1. The methodologic approach to corneal endothelial cell analysis. (A) An anterior segment SD-OCT image of a C57BL/6 mouse at baseline
(0 hours) and (B) immediately after corneal epithelial abrasion and the application of a TLR ligand to the injured region, to induce sterile corneal
inflammation. (C) A confocal image of the central corneal endothelium, stained immunohistochemically for ZO-1. The horizontal yellow lines were
used to derive a plot profile (D). To quantify corneal endothelial ZO-1 expression, the average number of peaks in the plot profile exceeding a pixel
intensity threshold, defined as twice the mean background intensity (green line), was determined for each horizontal line. (E) The central 50% of
each field was defined as an ROI and underwent image processing using a pseudo flat-field correction. (F) The image was further processed using a
series of binary operations to enhance the appearance of the endothelial borders and allow for the creation of a skeletonized representation of the
endothelial layer using a Voronoi matrix. (G) The degree of endothelial cell polymorphism was quantified by assessing the proportion of cells with
six sides within the ROI (green), as a proportion of the total number of cells. The colored scale on the left-hand side indicates the number of sides
for each cell.
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were hexagonal and an index of 0 indicates none of the cells
were hexagonal.
Statistical Analyses
Data were analyzed by masked observers. Descriptive statistics
are summarized as mean 6 SEM. Statistical analyses were
performed using unpaired, 2-tailed Student’s t-test or ANOVA
(GraphPad Prism, version 6.0; GraphPad Software, Inc., La
Jolla, CA, USA), followed by Bonferroni post hoc tests to
determine interactions in relation to the factors of time and
treatment group. Fisher’s exact test was used to compare
proportions. Pairwise correlations were explored using Spear-
man’s correlation coefficient (r). An alpha of 0.05 was
considered statistically significant.
RESULTS
Central Corneal Thickness
We previously reported that CpG-ODN induced corneal
inflammation is associated with increased corneal thickness
at 24 hours, but this subsides by 1 week.6 In the present study,
we included a later time point to examine whether the
resolution of corneal edema at 1 week marked the end of the
inflammatory response. Representative central anterior seg-
ment SD-OCT scans are shown 4 weeks after topical
application of saline (Fig. 2A) and CpG-ODN (Fig. 2B). Relative
to saline-treated eyes, mean CCT was increased in CpG-ODN–
treated eyes at 24 hours post treatment (Fig. 2C, P < 0.05). At 1
week, there was a relative normalization of CCT in CpG-ODN–
treated eyes with no significant difference between groups
(Fig. 2D, P > 0.05). By 4 weeks, CCT was again relatively
increased in CpG-ODN–treated eyes (Fig. 2E, P < 0.05). At 4
weeks, there was no significant difference in corneal epithelial
thickness between saline- and CpG-ODN–treated eyes (33.11
6 2.05 lm versus 52.68 6 11.08 lm; P ¼ 0.11), but stromal
thickness was relatively increased in CpG-ODN–treated eyes
(75.32 6 5.33 lm versus 127.4 6 18.27 lm; P ¼ 0.01; n ¼ 6
per group).
Corneal Endothelial ZO-1 Expression
Our original hypothesis was that CpG-induced corneal edema
would be associated with a downregulation of ZO-1. To examine
this relationship, we compared the expression intensity of ZO-1
in the corneal endothelium of CpG-treated eyes with age-
matched na¨ıve (untreated) and saline-treated eyes. Compared to
na¨ıve corneas, ZO-1 expression in the corneal endothelium was
unchanged in saline-treated eyes at each of 24 hours (Figs. 3A,
3C), 1 week (Figs. 3D, 3F), and 4 weeks (Figs. 3G, 3I). In eyes
treated with CpG-ODN, there was a significant reduction in
corneal endothelial expression of ZO-1 at 24 hours (Figs. 3B, 3C,
P < 0.05), which had returned to normal levels by 1 week (Figs.
3E, 3F) and then remained unchanged at 4 weeks post treatment
(Figs. 3H, 3I). There was no significant difference in corneal
endothelial expression of ZO-1 between saline- and CpG-ODN–
treated eyes at any time point.
Corneal ECD, Polymegethism, Polymorphism, and
Nucleus Size
Corneal endothelial polymegethism (measured using the CoV
for cell size); polymorphism (quantified with the hexagonality
index); and cell nucleus size are summarized in the Table.
There was no significant difference between any groups for
any of these parameters, at any of the time points. There was
no difference in corneal ECD between any of the groups at 24
hours or 1 week. At 4 weeks post treatment, corneal ECD was
reduced only in the CpG-ODN group, compared with na¨ıve
FIGURE 2. Quantification of CCT. Representative SD-OCT scans of (A) saline- and (B) CpG-ODN–treated eyes at 4 weeks post corneal injury. (C)
Corneal thickness was increased in CpG-treated eyes at 24 hours (P < 0.05), but had normalized (P > 0.05) by 1 week (D). At 4 weeks post
treatment, corneal thickness was again greater in CpG-ODN–treated eyes (P < 0.05). Data presented are mean6 SEM of six to nine mice per group.
*P < 0.05.
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eyes (Table). There was a moderately strong, negative
correlation between corneal ECD and CCT at 4 weeks (Fig.
4A, r¼0.57, P¼ 0.02). Plotting ECD data from all time points
against CCT demonstrated a similar correlation between these
parameters (Fig. 4B, r¼0.53, P ¼ 0.004).
Despite not reaching statistical significance, we observed a
slight upward trend in the CoV for endothelial cell size for
CpG-ODN–treated eyes. To explore this further, we dichoto-
mized the data to consider the proportion of eyes with a cell
size CoV above the mean of na¨ıve eyes at each time point,
which was defined as the threshold for ‘‘physiological
polymegethism.’’ This value corresponds closely with other
reports of normal CoV in the mouse cornea.16 At 24 hours,
only CpG-ODN eyes showed a relatively higher proportion of
FIGURE 3. Corneal endothelial ZO-1 expression. Representative confocal images of the central corneal endothelium stained for ZO-1 (red) and cell
nuclei (Hoechst, white) at (A, B) 24 hours, (D, E) 1 week and (G, H) 4 weeks post injury. (C) Compared with the na¨ıve group, a reduction in ZO-1
expression was evident in CpG-treated eyes only at 24 hours (P < 0.05); however, this reduction was not statistically significant when compared to
the saline group. This effect was attenuated by 1 week (F) and remained unchanged at 4 weeks (I). Data presented are mean 6 SEM of six to nine
mice per group. **P < 0.01.
TABLE. Corneal Endothelial Cell Density (ECD), Polymegethism (CoV), Polymorphism (hexagonality index, HEX%), and Nucleus Size
24 Hours 1 Week 4 Weeks
Naı¨ve,
n ¼ 7
Saline,
n ¼ 9
CpG-ODN,
n ¼ 10
Naı¨ve,
n ¼ 7
Saline,
n ¼ 6
CpG-ODN,
n ¼ 11
Naı¨ve,
n ¼ 9
Saline,
n ¼ 8
CpG-ODN,
n ¼ 8
ECD, lm2 2595 6 112 2505 6 62 2529 6 54 2595 6 112 2663 6 158 2365 6 27 2396 6 83 2245 6 78 2055 6 101*
CoV 18.2 6 1.7 19.6 6 1.9 20.4 6 0.9 18.2 6 1.7 17.7 6 1.9 19 6 1.0 19.3 6 1.2 22.7 6 1.1 23.4 6 2.2
HEX% 36 6 1.4 36 6 2.6 37 6 1.0 36 6 1.4 37 6 1.1 36 6 1.0 36 6 1.7 34 6 1.1 34 6 1.8
Nucleus, lm2 141 6 7 140 6 4 135 6 5 141 6 7 148 6 10 159 6 3 148 6 3 155 6 2 148 6 5
Data are shown as mean 6 SEM. HEX%, percent of hexagonal cells.
* P < 0.05 compared with na¨ıve eyes at the same time-point.
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cells with CoVs above threshold (Fig. 5A, P < 0.001). At 1
week and 4 weeks, both saline- and CpG-ODN–treated eyes
had a significantly higher proportion of cells with CoVs above
threshold (Fig. 5A, P < 0.001). Using a similar approach for cell
nucleus size, at 24 hours only CpG-ODN–treated eyes showed
a relatively higher percentage of cells with cell CoVs above
baseline threshold (Fig. 5B, P < 0.001). At 1 and 4 weeks, both
saline- and CpG-ODN–treated eyes had a higher proportion of
cells with cell nuclei size CoVs above threshold (Fig. 5B, P <
0.001).
Corneal Stromal Inflammatory Cells
In light of our previous reports of the presence of giant stromal
macrophages and the keratic precipitates adhering to the
corneal endothelium 1 week following topical CpG-ODN,13 we
examined whether the clinically observable corneal edema
(Fig. 2B) and alterations to the corneal endothelium (Table)
were associated with persistence of inflammatory cells in the
cornea after 4 weeks. Compared with saline-treated corneas,
which exhibited normal numbers of stromal leukocytes (Fig.
6A), there were elevated numbers of large CD45þ cells
throughout the corneal stroma (Figs. 6B, 6C) at 4 weeks post
treatment (P < 0.05).
DISCUSSION
Experimental models of sterile TLR activation provide impor-
tant insights into the nature of host inflammatory responses to
particular pathogen-associated molecular patterns. Cytosine-
phosphate-guanosine–DNA is a synthetic mimic of unmethy-
lated DNA that induces transcriptional activation of proin-
flammatory cytokines in a TLR9-dependent manner.17 Many
studies have utilized CpG to mimic the inflammatory response
that ensues during microbial infections in a range of tissues,
including the lung,18 brain,19 and skin.20 In the mouse cornea,
CpG induces inflammation that closely parallels the immuno-
pathology associated with herpes simplex virus type I (HSV-1)
keratitis, including stromal lesions,21 angiogenesis,22 chemo-
kine production23 and activated macrophages.13 Our laborato-
ry, and others, have previously reported that acute corneal
inflammation induced by topical CpG is associated with
corneal edema, as indicated by increased CCT at 24 hours,11
which subsides by 1 week post treatment.6 To explore the
mechanisms underlying this CpG-induced stromal edema, we
investigated the expression of the tight junction protein ZO-1
and other indices of endothelial integrity including cell density,
polymorphism, and polymegethism over 4 weeks.
The expression of tight junctions in the basolateral
compartment of corneal endothelial cells is vital for the
maintenance of deturgescence.24 In our model of CpG-induced
inflammation, ZO-1 expression was significantly reduced in the
endothelium at 24 hours, when compared with na¨ıve corneas,
but this had resolved by 1 week post treatment. However, the
lack of difference between the saline and CpG-treated groups
suggests there is no major role for ZO-1 expression in the
maintenance of corneal hydration during the acute phase of
CpG-induced inflammation.
The physiological attrition of corneal endothelial cells
during aging is well described in both humans25 and mice.26
In one study of age-related changes in the normal mouse
corneal endothelium, there was a 10% decrease in ECD the
ages of 6 and 16 weeks. To avoid any age-related changes
impacting upon differences in ECD in our experimental
groups, particularly at the 4-week time point, we included
age-matched control animals. We found that treatment with the
TLR-9 agonist, CpG, led to a 15% reduction in ECD compared
with age-matched controls after 4 weeks. This decrease in ECD
FIGURE 4. Relationship between corneal ECD and CCT. (A) Plot showing the relationship between ECD and CCT in na¨ıve (black circles), saline-
treated (black triangles) and CpG-treated (red squares) eyes at 4 weeks. There was a significant negative correlation between ECD and CCT (r¼
0.57, P¼0.02). (B) Plot showing the relationship between ECD and CCT for all eyes at all time points. There was a significant negative correlation
between ECD and CCT (r ¼0.53, P¼ 0.004).
FIGURE 5. Quantification of corneal endothelial cell polymegethism and cell nucleus size. Graphs showing the proportion of eyes with a cell size
CoV exceeding the mean of na¨ıve (untreated) eyes for (A) polymegethism and (B) nucleus size. At 24 hours, only CpG-ODN eyes had a relatively
higher proportion of cells with CoVs above threshold for both polymegethism and nucleus size (P < 0.001). At 1 and 4 weeks, both saline- and CpG-
ODN–treated eyes had a higher proportion of cells with CoVs above threshold (P < 0.001). Data presented are mean 6 SEM of six to nine mice per
group. **P < 0.01. ***P < 0.001. ns, not statistically significant; P > 0.05.
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was not associated with the presence of keratic precipitates,
which were identifiable only at 1 week, nor altered expression
of the tight junction protein, ZO-1. In a clinical study that
examined endothelial cell changes in patients with HSV-1
endotheliitis, a 10% decline in ECD was reported after 1 year,
despite clinical improvement in other endothelial alterations
such as pseudoguttata and keratic precipitate infiltration.1
These findings closely parallel our data, which indicate for the
longer-term effects of chronic inflammation on the density of
corneal endothelial cells.
In addition to the well-recognized detrimental effects of long-
term contact lens wear on endothelial health, which occur
mostly due to hypoxia,27,28 the involvement of the corneal
endothelium in response to epithelial or ocular surface
abnormalities is gaining increasing attention. Endothelial cell
density is reduced in patients with dry eye disease29 and
neurotrophic keratitis,30 supporting a close interaction between
ocular surface health and the integrity of the corneal
endothelium. Our data suggest that a sterile, debridement injury
to the corneal epithelium is sufficient to induce polymegethism
of endothelial cells after 1 week, which persists up to 4 weeks.
In the presence of CpG-ODN, endothelial polymegethism is
observed after 24 hours and remains until at least 4 weeks after
exposure. The observed morphologic changes in endothelial
cells at 1 week are independent of the presence of keratic
precipitates and activated stromal macrophages, which are a
known feature of corneal inflammation in response to CpG-
treatment.13 For all conditions, the absolute degree of endothe-
lial cell hexagonality was unchanged, supporting the concept
that polymegethism is a more sensitive index of corneal
endothelial responses to inflammation/injury than the degree
of hexagonality (pleomorphism).16
We recently reported the presence of large, multinucleated
giant macrophages in the mouse cornea 1 week after CpG-
ODN treatment; however, this was not associated with any
overt corneal endothelial dysfunction.13 In the present study,
intact ZO-1 expression, normal CCT, and normal ECD were
observed in all groups at 1 week post treatment; however,
there was reduced ECD and increased CCT at 4 weeks after
CpG-ODN treatment. These signs of corneal pathology in the
CpG-ODN–treated group were associated with the presence of
enlarged CD45þ cells throughout the corneal stroma, indicat-
ing persistent activation of inflammatory cells. Elevated
numbers of leukocytes in the corneal stroma are a feature of
chronic inflammatory processes such as allograft rejection,31
herpetic stromal keratitis,32 and trauma-induced neovascular-
ization.33 A recent study on the pathologic capacity of
activated monocyte-derived cells during allograft rejection
provides evidence that macrophage-derived cytokines, includ-
ing interferon-c, can directly induce corneal endothelial cell
death in vitro.34 Thus, it is possible that the persistence of
activated leukocytes in our model of CpG-ODN–induced
corneal inflammation contributes to the observed decline in
endothelial cell density and the increased corneal thickness at
4 weeks post treatment.
Our data demonstrate that CpG-ODN–induced corneal
inflammation is associated with reduced endothelial density,
increased corneal thickness, and presence of activated
leukocytes 4 weeks after topical treatment in mice. These
chronic signs of inflammation occur independently of alter-
ations to the expression of tight junction protein zonula
occludens-1. The use of topically applied toll-like receptor-9
agonists to the injured mouse epithelium provides a model to
investigate the interplay between chronic stromal leukocyte
activation, corneal edema, and endothelial integrity during
sterile corneal inflammation.
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